Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 25, Issue 12, 2013, Pages 1599-1603

  Casado, José L ^a   Iglesias, Verónica ^a   Del Palacio, María ^a   Marín, Ana ^a   Perez Elías, María J ^a   Moreno, Ana ^a   Moreno, Santiago ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

HIV infection; Lipodystrophy; psychological; quality of life; social isolation

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL INTERACTION; SOCIAL ISOLATION; SOCIAL STRESS; ADVERSE EFFECTS; BODY IMAGE; CASE CONTROL STUDY; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PSYCHOLOGY;

ABSORPTIOMETRY, PHOTON; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY IMAGE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SOCIAL ISOLATION;

EID: 84888199218     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2013.793275     Document Type: Article

References (23)

1. Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P.,AdICONA. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445-449. PMID: 11744832
2. Bonnet, E., Delpierre, C., Sommet, A., Marion-Latard, D., Herve, R., Aquilina, C., Bernard, J. (2005). Total body composition by DXA of 241 HIV negative men and 162 HIV infected men. Journal of Clinical Densitometry, 8(3), 287-292. doi:10.1385/JCD:8:3:287
3. Burgoyne, R., Collins, E., Wagner, C., Abbey, S., Halman, M., Nur, M., & Walmsley, C. (2005). The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIVpositive adults. Quality of Life Research, 14(4), 981-990. doi:10.1007/s11136-004-2580-2
4. Cabrero, E., Griffa, L., Burgos, A., & HIV Body Physical Changes Study Group. (2010). Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: Results from a study on patient and physician perceptions. AIDS Patient Care and STDs, 24, 5-13. doi:10.1089/apc. 2009.0191
5. Collins, E., Wagner, C., & Walmsley, S. (2000). Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Reader, 10, 546-550. PMID: 1101 9453.
6. Crane, H. M., Grunfeld, C., Harrington, R. D., Uldall, K. K., Ciechanowski, P. S., & Kitahata, M. M. (2008). Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy. HIV Medicine, 9, 780-786. doi:10.1111/j.1468-1293. 2008.00631.x
7. Duran, S., Saves, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P.,..APROCO Study Group. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS, 15(18), 2441-2444. doi:doi:10.1097/00002030-200112070-00012
8. Freitas, P., Santos, A. C., Carvalho, D., Pereira, J., Marques, R., Martinez, E., Medina, J. L. (2010). Fat mass ratio: An objective tool to define lipodystrophy in HIV infected patients under antiretroviral therapy. Journal of Clinical Densitometry, 13(2), 197-203. doi:10.1016/j.jocd.2010.01.005
9. Fukunishi, I. (1999). Relationship of cosmetic disfigurement to the severity of posttraumatic stress disorder in burn injury or digital amputation. Psychotherapy and Psychosomatics, 68(2), 82-86. doi:10.1159/000012317
10. Guaraldi, G., Murri, R., Orlando, G., Giovanardi, C., Squillace, N., Vandelli, M., Wu, A. M. (2008). Severity of lipodystrophy is associated with decreased health-related quality of life. AIDS Patient Care and STDs, 22(7), 577-585. doi:10.1089/apc.2007.0173
11. Guaraldi, G., Murri, R., Orlando, G., Orlandi, E., Sterrantino, G., Borderi, M.,.. Wu, A. W. (2003). Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clinical Trials, 4(2), 99-106. doi:10. 1310/W1QF-C9X9-9PFT-88JK
12. Knobel, H., Alonso, J., Casado, J. L., Collazos, J., Gonzalez, J., Ruiz, I.,GEEMA Study Group. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA study. AIDS, 16(4), 605-613. doi:10.1097/00002030-200203080-00012
13. Lenert, L., Feddersen, M., Sturley, A., & Lee, D. (2002). Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. The American Journal of Medicine, 113(3), 229-232. doi:10.1016/S0002-9343 (02)01156-7
14. Marin, A., Casado, J. L., Aranzabal, L., Moya, J., Antela, A., Moreno, A., Moreno, S. (2004). Identification of factors related to social distress and anxiety in HIVinfected patients with Lipodystrophy Syndrome. Paper presented at the XV International AIDS Conference, Bangkok, Thailand. [Abstract MoPeD3809].
15. Marin, A., Casado, J. L., Aranzabal, L., Moya, J., Antela, A., Dronda, F., Moreno, S. (2006). Validation of a specific questionnaire on psychological and social repercussions of the lipodystrophy syndrome in HIVinfected patients. Quality of Life Research, 15(5), 767-775. doi:10.1007/s11136-005-5001-2
16. Power, R., Tate, H., McGill, S. M., & Taylor, C. (2003). A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sexually Transmitted Infections, 79(2), 137-141. doi:10.1136/sti.79.2.137
17. Price, J., Woolley, I., Paul, E., Ridley, E., Nyulasi, I., Hoy, J. (2011). Lipodystrophy: Is it still relevant. Paper presented at the 6th IAS Conference on HIV Pathogenesis and Treatment and Prevention, Roma, Italy. [Abstract MOPE264].
18. Rajagopalan, R., Laitinen, D., & Dietz, B. (2008). Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy. AIDS Care, 20(10), 1197-1201. doi:10.1080/09540120801926993
19. Rakotoambinina, B., Medioni, J., Rabian, C., Jubault, V., Jais, J. P., & Viard, J. P. (2001). Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor. Journal of Acquired Immune Deficiency Syndromes, 27, 443-449. PMID: 11511820.
20. Savard, J., Laberge, B., Gauthier, J. G., & Bergeron, M. G. (1999). Screening clinical depression in HIV-seropositive patients using the hospital anxiety and depression scale. AIDS and Behavior, 3(2), 167-175. doi:10.1023/A:1025444225120
21. Smith, D. E., Hudson, J., Martin, A., Freund, J., Griffiths, M. R., Kalnins, S., PIILR DEXA Group. (2003). Centralized assessment of dual-energy X-ray absorptiometry (DEXA) in multicenter studies of HIVassociated lipodystrophy. HIV Clinical Trials, 4(1), 45-49. doi:10.1310/WRL8-DWH1-7VQL-AK81
22. Steel, J., Landsittel, D., Calhoun, B., Wieand, S., & Kingsley, L. (2006). Effects of lipodystrophy on QoL and depression in HIV-infected men on HAART. AIDS Patient Care and STDS, 20, 565-575. doi:10. 1089/apc.2006.20.565
23. Tungsiripat, M., O'Riordan, M. A., Storer, N., Harrill, D., Ganz, J., Libutti, D., McComsey, G. A. (2009). Subjective clinical lipoatrophy assessment correlates with DEXA-measured limb fat. HIV Clinical Trials, 10(5), 314-319. doi:10.1310/hct1005-314